Skip to main content
Top
Published in: Journal of NeuroVirology 3/2017

01-06-2017

Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007–2014)

Authors: M. Arruti, LD. Piñeiro, Y. Salicio, G. Cilla, MA. Goenaga, A. López de Munain

Published in: Journal of NeuroVirology | Issue 3/2017

Login to get access

Abstract

The aim of the study was to describe the clinical and epidemiological characteristics of the central nervous system (CNS) infection by varicella zoster virus (VZV) in patients older than 65 years in a tertiary community hospital. We retrospectively analysed the results of cerebrospinal fluid (CSF) testing in patients older than 65 years between 2007 and 2014 with clinically suspected VZV infection with CNS involvement. Patients whose CSF samples were positive for VZV DNA were included, as were those with negative results who simultaneously presented herpes zoster and CSF or magnetic resonance imaging findings suggestive of CNS infection, and in whom other possible aetiologies had been ruled out. The study included 280 patients. The disease was considered to be caused by a VZV infection in 32 patients (11.4%), of which 23 cases were virologically confirmed (detection of VZV DNA in CSF). The most frequent diagnosis of the patients with VZV CNS infection was encephalitis (83.3%), followed by meningitis (13.3%) and cerebellitis (3.3%). The mean annual incidence of VZV CNS infection was 3.0 cases per 100,000 inhabitants. VZV was the most common cause of encephalitis and viral meningitis, ahead of herpes simplex virus (n = 9). At the time of discharge, 12 (40%) patients showed neurological sequelae. Five patients (20%) died during hospitalization, all with encephalitis. Patients with a fatal outcome had significantly higher median age and longer delay before initiating acyclovir. In conclusion, VZV was the first cause of encephalitis in our elderly population. Despite acyclovir treatment, there was a high rate of case fatality and sequelae at discharge.
Literature
go back to reference Aberle SW, Aberle JH, Steininger C, Puchhammer-Stöckl E (2005) Quantitative real time PCR detection of varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 194:7–12CrossRefPubMed Aberle SW, Aberle JH, Steininger C, Puchhammer-Stöckl E (2005) Quantitative real time PCR detection of varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 194:7–12CrossRefPubMed
go back to reference Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17:e529–e534CrossRefPubMed Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17:e529–e534CrossRefPubMed
go back to reference Blein C, Gavazzi G, Paccalin M, Baptiste C, Berrut G, Vainchtock A (2015) Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France. BMC Infect Dis 15:350CrossRefPubMedPubMedCentral Blein C, Gavazzi G, Paccalin M, Baptiste C, Berrut G, Vainchtock A (2015) Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France. BMC Infect Dis 15:350CrossRefPubMedPubMedCentral
go back to reference Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ (1982) Immune responses to varicella-zoster in the aged. Arch Intern Med 142:291–293CrossRefPubMed Burke BL, Steele RW, Beard OW, Wood JS, Cain TD, Marmer DJ (1982) Immune responses to varicella-zoster in the aged. Arch Intern Med 142:291–293CrossRefPubMed
go back to reference Centers for Disease Control and Prevention (CDC) (1996) Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45:1–36 Centers for Disease Control and Prevention (CDC) (1996) Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45:1–36
go back to reference Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J et al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019–1032CrossRefPubMed Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J et al (2016) Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019–1032CrossRefPubMed
go back to reference De Broucker T, Mailles A, Chabrier S, Morand P (2012) Stahl JP; steering committee and investigators group. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18:808–819CrossRefPubMed De Broucker T, Mailles A, Chabrier S, Morand P (2012) Stahl JP; steering committee and investigators group. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18:808–819CrossRefPubMed
go back to reference de Ory F, Avellón A, Echevarría JE, Sánchez-Seco MP, Trallero G, Cabrerizo M et al (2013) Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 85:554–562CrossRefPubMed de Ory F, Avellón A, Echevarría JE, Sánchez-Seco MP, Trallero G, Cabrerizo M et al (2013) Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 85:554–562CrossRefPubMed
go back to reference Esteban-Vasallo MD, Domínguez-Berjón MF, Gil-Prieto R, Astray-Mochales J, Gil de Miguel Á (2015) Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003-2013. J Infect 71:85–92CrossRefPubMed Esteban-Vasallo MD, Domínguez-Berjón MF, Gil-Prieto R, Astray-Mochales J, Gil de Miguel Á (2015) Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003-2013. J Infect 71:85–92CrossRefPubMed
go back to reference Gil A, San-Martín M, Carrasco P, González A (2004) Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 22:3947–3951CrossRefPubMed Gil A, San-Martín M, Carrasco P, González A (2004) Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 22:3947–3951CrossRefPubMed
go back to reference Grahn A, Studahl M (2015) Varicella-zoster virus infections of the central nervous system—prognosis, diagnostics and treatment. J Infect 71:281–293CrossRefPubMed Grahn A, Studahl M (2015) Varicella-zoster virus infections of the central nervous system—prognosis, diagnostics and treatment. J Infect 71:281–293CrossRefPubMed
go back to reference Grahn A, Hagberg L, Nilsson S, Blennow K, Zetterberg H, Studahl M (2013) Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol 260:1813–1821CrossRefPubMed Grahn A, Hagberg L, Nilsson S, Blennow K, Zetterberg H, Studahl M (2013) Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J Neurol 260:1813–1821CrossRefPubMed
go back to reference Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844CrossRefPubMed Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844CrossRefPubMed
go back to reference Kadambari S, Okike I, Ribeiro S, Ramsay ME, Heath PT, Sharland M et al (2014) Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. J Infect. 69:326–332CrossRefPubMed Kadambari S, Okike I, Ribeiro S, Ramsay ME, Heath PT, Sharland M et al (2014) Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013. J Infect. 69:326–332CrossRefPubMed
go back to reference Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R (2016) Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 44:337–345CrossRefPubMed Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R (2016) Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 44:337–345CrossRefPubMed
go back to reference Kawai K, Gebremeskel BG, Acosta CJ (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4(6):e004833CrossRefPubMedPubMedCentral Kawai K, Gebremeskel BG, Acosta CJ (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4(6):e004833CrossRefPubMedPubMedCentral
go back to reference Mailles A, Stahl JP (2009) Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847CrossRefPubMed Mailles A, Stahl JP (2009) Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847CrossRefPubMed
go back to reference Miller AE (1980) Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582–587CrossRefPubMed Miller AE (1980) Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582–587CrossRefPubMed
go back to reference Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN et al (2007) The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069–1073CrossRefPubMed Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN et al (2007) The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069–1073CrossRefPubMed
go back to reference Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284CrossRefPubMed Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284CrossRefPubMed
go back to reference Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS (2011) Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 203:316–323CrossRefPubMedPubMedCentral Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS (2011) Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 203:316–323CrossRefPubMedPubMedCentral
go back to reference Parisi SG, Basso M, Del Vecchio C, Andreis S, Franchin E, Dal Bello F et al (2016) Viral infections of the central nervous system in elderly patients: a retrospective study. Int J Infect Dis 44:8–10CrossRefPubMed Parisi SG, Basso M, Del Vecchio C, Andreis S, Franchin E, Dal Bello F et al (2016) Viral infections of the central nervous system in elderly patients: a retrospective study. Int J Infect Dis 44:8–10CrossRefPubMed
go back to reference Persson A, Bergström T, Lindh M, Namvar L, Studahl M (2009) Varicella-zoster virus CNS disease—viral load, clinical manifestations and sequels. J Clin Virol 46:249–253CrossRefPubMed Persson A, Bergström T, Lindh M, Namvar L, Studahl M (2009) Varicella-zoster virus CNS disease—viral load, clinical manifestations and sequels. J Clin Virol 46:249–253CrossRefPubMed
go back to reference Rottenstreich A, Oz ZK, Oren I (2014) Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection. Diagn Microbiol Infect Dis 79:174–177CrossRefPubMed Rottenstreich A, Oz ZK, Oren I (2014) Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection. Diagn Microbiol Infect Dis 79:174–177CrossRefPubMed
go back to reference Studahl M, Petzold M, Cassel T (2013) Disease burden of herpes zoster in Sweden—predominance in the elderly and in women—a register based study. BMC Infect Dis 13:586CrossRefPubMedPubMedCentral Studahl M, Petzold M, Cassel T (2013) Disease burden of herpes zoster in Sweden—predominance in the elderly and in women—a register based study. BMC Infect Dis 13:586CrossRefPubMedPubMedCentral
go back to reference Weil AA, Glaser CA, Amad Z, Forghani B (2002) Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymersae chain reaction result. Clin Infect Dis 34:1154–1157CrossRefPubMed Weil AA, Glaser CA, Amad Z, Forghani B (2002) Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymersae chain reaction result. Clin Infect Dis 34:1154–1157CrossRefPubMed
go back to reference Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82:1341–1349CrossRefPubMed Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82:1341–1349CrossRefPubMed
Metadata
Title
Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007–2014)
Authors
M. Arruti
LD. Piñeiro
Y. Salicio
G. Cilla
MA. Goenaga
A. López de Munain
Publication date
01-06-2017
Publisher
Springer International Publishing
Published in
Journal of NeuroVirology / Issue 3/2017
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-017-0519-y

Other articles of this Issue 3/2017

Journal of NeuroVirology 3/2017 Go to the issue